EUVIMEDEUVIMED entdecken
Fallbericht

TREX‐1 related Aicardi‐Goutières syndrome improved by Janus kinase inhibitor

Claire Ryckmans iD, Mylène Donge, Antonia Marchèse, Meriem Mastouri, Caroline Thomee, Katrien Stouffs, Sandra-Lucile Lieser, Emmanuel Scalais

American Journal of Medical Genetics Part A · 2024-05 · 194 (5)

DOI: 10.1002/ajmg.a.63510 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 22.12.2023. Verfasst von Claire Ryckmans und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Neurology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Lymphocytosis, Nervous System Malformations, Basal Ganglia Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aicardi‐Goutières syndrome (AGS) is a genetic interferonopathy classically characterized by early onset of severe neurologic injury with basal ganglia calcifications, white matter abnormalities, and progressive cerebral atrophy, along with lymphocytosis and raised interferon alpha (INFα) in the cerebrospinal fluid (CSF). Here, we report a 3 1/2 year‐old patient born with prenatal onset AGS, first manifesting as intra‐uterine growth retardation. Cranial ultrasonography and cerebral MRI revealed ventriculomegaly and periventricular and basal ganglia calcifications, along with cerebral atrophy. Perinatal infections and known metabolic disorders were excluded. Both CSF lymphocytosis and raised INFα were present. Molecular analysis disclosed two already described compound heterozygous pathogenic variants in TREX1 ( c. 309dup , p. ( Thr104Hisfs*53 ) and c. 506G > A , p. ( Arg169His )). The evolution was marked by severe global developmental delay with progressive microcephaly. Promptly, the patient developed irritability, quadri‐paretic dyskinetic movements, and subsequently tonic seizures. Sensorineural hearing loss was detected as well as glaucoma. Initially, he was symptomatically treated with trihexyphenidyl followed by levetiracetam and topiramate. At age 22 months, baricitinib (0.4 mg/kg/day) was introduced, leading to normal serum INFα levels. Clinically, dyskinetic movements significantly decreased as well as irritability and sleep disturbance. We confirmed that baricitinib was a useful treatment with no major side effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase InhibitorsLymphocytosisNervous System MalformationsBasal Ganglia DiseasesAutoimmune Diseases of the Nervous SystemCalcinosisAzetidinesPurinesPyrazolesSulfonamidesMalePregnancyFemaleHumansInfantAtrophy

Stichwörter der Autor:innen

Aicardi‐Goutières syndromeJanus kinase inhibitorTREX1 geneinterferonopathy

Substanzen

baricitinibJanus Kinase InhibitorsAzetidinesPurinesPyrazolesSulfonamides

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Neurology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
  • Department of Pediatrics, General Pediatric Service, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
  • Clinical Sciences, Research Group Reproduction and Genetics, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
  • General Pediatric Service, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.

ORCID-Profile: Claire Ryckmans

Zitieren

APA

Ryckmans, C., Donge, M., Marchèse, A., Mastouri, M., Thomee, C., Stouffs, K., Lieser, S. L., & Scalais, E. (2024). TREX‐1 related Aicardi‐Goutières syndrome improved by Janus kinase inhibitor. American Journal of Medical Genetics Part A, 194(5). https://doi.org/10.1002/ajmg.a.63510

Vancouver

Ryckmans C, Donge M, Marchèse A, Mastouri M, Thomee C, Stouffs K, et al. TREX‐1 related Aicardi‐Goutières syndrome improved by Janus kinase inhibitor. American Journal of Medical Genetics Part A. 2024;194(5). doi:10.1002/ajmg.a.63510

BibTeX
@article{Ryckmans2024,
  author = {Ryckmans, Claire and Donge, Mylène and Marchèse, Antonia and Mastouri, Meriem and Thomee, Caroline and Stouffs, Katrien and Lieser, Sandra-Lucile and Scalais, Emmanuel},
  title = {TREX‐1 related Aicardi‐Goutières syndrome improved by Janus kinase inhibitor},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  volume = {194},
  number = {5},
  doi = {10.1002/ajmg.a.63510}
}
Kostenlos starten →